Aqueous Shunts and Stents for Glaucoma
Summary
FDA-approved ab externo aqueous shunts and FDA-approved ab interno aqueous stents are considered medically necessary to reduce intraocular pressure in individuals with glaucoma where medical therapy has failed to adequately control intraocular pressure. Implantation of 1 or 2 FDA-approved ab interno stents with cataract surgery may be considered medically necessary in individuals with mild-to-moderate open-angle glaucoma treated with ocular hypotensive medication. Ab externo shunts and ab interno stents used for all other conditions, including glaucoma where intraocular pressure is adequately controlled by medications, are considered investigational.
Get alerts when payers change rules like this one
We check Blue Cross & Blue Shield of Mississippi and other payers every day and email you when a change matches your specialty and state.